You’ll inject Humira under your skin. Your doctor will show you how to give Humira injections to yourself. Be sure to let your doctor know if you have any questions or concerns about ...

Since Humira is an injection, it may be covered through Medicare Part D, Medicare’s prescription drug coverage, if you can administer it to yourself at home. If you are not able to administer it ...

It also boasts a twist deployment. When you give the grenade-pattered machined tip a twirl, its cartridge protrudes from the tip. Sadly, Cobratec hasn’t revealed what types of ink cartridges this pen ...

While AstraZeneca had said the price negotiations would impact its ability to make research and development decisions, the court said it failed to give an example of how that impact had materialized.

Obviously, to give everyone a chance ... IV and then vials, pen injector and stuff. Now when it comes to Otulfi, if I say it will be more HUMIRA like, don't get too crazy because HUMIRA was ...

"By recycling them, we can help to give these materials new purpose ... "Up to 85% of the materials in every pen returned to Novo Nordisk will be recycled, preventing up to 12 tonnes of plastic ...

The drug comes in two forms: a disposable, prefilled FlexTouch injection pen and a vial for use with ... it’s being used to manage. Try to administer your daily Tresiba dose at the same time ...

Glucagon can be given by simple injection into the fat of the belly, thigh, or arm, or by using a prefilled pen-like device ... If they don’t know how to give you the injection or if glucagon ...

The approval for interchangeability was supported by data from a phase 4 trial that assessed the pharmacokinetics, efficacy, safety, and immunogenicity of Hadlima vs Humira in patients with moderate ...

Fact checked by Jennifer Klump About the Author Huma Sheikh, MD, is a neurologist who specializes in migraine and stroke. She ...

The reality is more complex: Successful implementation depends just as much on operational alignment, cultural change and ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...